Systemic Thrombolysis Versus Catheter Directed Management for Acute Intermediate-high Pulmonary Embolism

ConditionAcute Pulmonary Embolism

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorAssiut University

About this trial

To compare in hospital clinical outcomes and one month follow up of systemic thrombolysis versus catheter directed management for the treatment of acute intermediate- high risk pulmonary embolism (using streptokinase or tissue plasminogen activator (TPA) and catheter-based intervention group using Penumbra System).

Eligibility criteria

Qualifiers

None

Disqualifiers

Patients less than 18 years of age.

Low risk, intermediate low risk, acute pulmonary embolism

patients with RV masses will be excluded.

Patient refusal of treatment strategy.

Trial design

Treatments tested in this trial

Streptokinase Injection
Penumbra System

Treatment groups

50 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Assiut University

Lead sponsor

Source ClinicalTrials.gov